Similar articles for PMID: 25593113

Year	Number of Results
1949	1
1950	1
1964	1
1978	1
1985	1
1989	1
1999	2
2002	2
2003	1
2005	1
2006	2
2007	4
2008	1
2009	6
2010	4
2011	7
2012	8
2013	9
2014	16
2015	10
2016	12
2017	13
2018	14
2019	4
2020	3
2021	5
2022	5
2023	1
2024	0

1

18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.

Hillner BE, Siegel BA, Hanna L, Duan F, Quinn B, Shields AF. Hillner BE, et al. J Nucl Med. 2015 Feb;56(2):222-8. doi: 10.2967/jnumed.114.150391. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593113 Free article. Clinical Trial.

2

Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.

Hillner BE, Siegel BA, Hanna L, Duan F, Shields AF, Coleman RE. Hillner BE, et al. J Nucl Med. 2014 Apr;55(4):574-81. doi: 10.2967/jnumed.113.130005. Epub 2014 Feb 27. J Nucl Med. 2014. PMID: 24578240 Free article.

3

Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry.

Hillner BE, Siegel BA, Hanna L, Duan F, Shields AF, Quinn B, Coleman RE. Hillner BE, et al. J Nucl Med. 2014 Jul;55(7):1054-61. doi: 10.2967/jnumed.113.135475. Epub 2014 May 12. J Nucl Med. 2014. PMID: 24819422 Free article.

4

Intended Versus Inferred Treatment After ¹⁸F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.

Hillner BE, Hanna L, Makineni R, Duan F, Shields AF, Subramaniam RM, Gareen I, Siegel BA. Hillner BE, et al. J Nucl Med. 2018 Mar;59(3):421-426. doi: 10.2967/jnumed.117.205047. Epub 2017 Nov 30. J Nucl Med. 2018. PMID: 29191854 Free PMC article.

5

Hospice Admission and Survival After ¹⁸F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.

Gareen IF, Hillner BE, Hanna L, Makineni R, Duan F, Shields AF, Subramaniam RM, Siegel BA. Gareen IF, et al. J Nucl Med. 2018 Mar;59(3):427-433. doi: 10.2967/jnumed.117.205120. Epub 2017 Dec 28. J Nucl Med. 2018. PMID: 29284672 Free PMC article.

6

Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.

Hillner BE, Siegel BA, Hanna L, Shields AF, Duan F, Gareen IF, Quinn B, Coleman RE. Hillner BE, et al. J Nucl Med. 2012 May;53(5):831-7. doi: 10.2967/jnumed.112.103911. Epub 2012 Mar 23. J Nucl Med. 2012. PMID: 22448033 Free article.

7

Intra-individual comparison of ¹⁸F-sodium fluoride PET-CT and ^99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.

Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC. Bénard F, et al. Lancet Oncol. 2022 Dec;23(12):1499-1507. doi: 10.1016/S1470-2045(22)00642-8. Epub 2022 Nov 4. Lancet Oncol. 2022. PMID: 36343655 Clinical Trial.

8

Prospective comparative study of ¹⁸F-sodium fluoride PET/CT and planar bone scintigraphy for treatment response assessment of bone metastases in patients with prostate cancer.

Fonager RF, Zacho HD, Langkilde NC, Fledelius J, Ejlersen JA, Hendel HW, Haarmark C, Moe M, Mortensen JC, Jochumsen MR, Petersen LJ. Fonager RF, et al. Acta Oncol. 2018 Aug;57(8):1063-1069. doi: 10.1080/0284186X.2018.1438651. Epub 2018 Feb 15. Acta Oncol. 2018. PMID: 29447047 Clinical Trial.

9

18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.

Piccardo A, Puntoni M, Morbelli S, Massollo M, Bongioanni F, Paparo F, Altrinetti V, Gonella R, Gennari A, Iacozzi M, Sambuceti G, DeCensi A. Piccardo A, et al. Nuklearmedizin. 2015;54(4):163-72. doi: 10.3413/Nukmed-0727-15-02. Epub 2015 Jul 13. Nuklearmedizin. 2015. PMID: 26165806

10

[State of the art in nuclear imaging for the diagnosis of bone metastases].

Ouvrier MJ, Vignot S, Thariat J. Ouvrier MJ, et al. Bull Cancer. 2013 Nov;100(11):1115-24. doi: 10.1684/bdc.2013.1847. Bull Cancer. 2013. PMID: 24153039 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year